查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2130586

組織工程領域3D生物列印市場分析及預測（至2035年）：依類型、產品、服務、技術、組件、應用、材料類型、製程、最終用戶及功能分類

3D Bioprinting for Tissue Engineering Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Material Type, Process, End User, Functionality
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球用於組織工程的3D生物列印市場預計將從2025年的14億美元成長到2035年的49億美元，複合年成長率（CAGR）為13.3%。推動這一市場成長的因素包括：再生醫學需求的不斷成長、人工組織研究的進展以及生醫材料和生物列印技術的進步。據美國國立衛生研究院（NIH）稱，3D生物列印技術使研究人員能夠將活細胞與支架材料結合，從而建立複雜的3D組織模型。生物墨水、幹細胞、擠出列印、雷射輔助技術和生醫材料工程的進步，使得開發用於骨骼、軟骨、皮膚和其他應用的客製化組織結構成為可能。美國食品藥物管理局（FDA）也將含有細胞的3D列印支架定位為新的再生醫學方法，並支持正在進行的研究和開發。

組織工程3D生物列印市場的「方法」細分領域包括擠出、噴墨、雷射、微閥等技術。預計到2025年，擠出生物列印將佔據最大市場佔有率，這主要得益於其能夠列印生醫材料和含細胞生物墨水、擴充性以及適用於製造複雜組織支架。雷射生物列印預計將成為成長最快的細分領域，這主要得益於其高列印精度、可控的細胞定位以及在先進組織工程和再生醫學領域日益廣泛的應用。噴墨和微閥技術對於細胞和生醫材料的精確沉積仍然至關重要，「其他」細分領域則包括新興的生物列印方法。

市場區隔
類型 擠出式、噴墨式、雷射、微閥式等。
產品 3D生物列印機、生醫材料、支架、軟體及其他
服務 客製化原型開發、諮詢、維護、培訓等。
科技 磁浮、立體光刻技術、數位光處理、熔融沈積成型等技術。
成分 硬體、軟體、生醫材料及其他
目的 組織工程、藥物測試與開發、再生醫學研究等。
材料類型 水凝膠、活細胞、細胞外基質、合成聚合物等。
過程 預處理、處理、後處理及其他
最終用戶 研究機構、生物製藥公司、醫院、學術機構及其他
功能 細胞列印、支架列印、器官列印等等

3D生物列印技術在組織工程領域的應用涵蓋組織工程、藥物測試與研發、再生醫學、科研等。到2025年，組織工程將佔據最大市場佔有率，這主要得益於3D生物列印技術在仿生支架、組織構建體和細胞模型開發方面的廣泛應用，這些模型旨在修復和替代受損組織。再生醫學預計將成為成長最快的領域，這得益於細胞療法、個人化醫療、器官和組織建構以及生物植入開發的進步。在藥物測試與研發領域，生物列印組織模型的應用正在不斷擴展，以改善藥物篩檢；同時，科學研究應用也持續支持技術的開發與檢驗。

區域概覽

到2025年，北美將佔據組織工程3D生物列印市場最大的佔有率。該地區的主導地位得益於先進的生物技術和醫療保健基礎設施、雄厚的研究經費以及大學、生物技術公司、製藥公司和醫療機構之間的緊密合作。美國仍是主要貢獻者，不斷增加對再生醫學、組織工程、藥物研發和生物列印組織研究的投資。人工組織臨床研究的不斷深入，以及生物墨水、擠出技術和光學列印技術的進步，正在增強商業性機會。監管政策的進步和對個人化及再生醫學投資的增加也鞏固了北美的主導地位。

在預測期內，亞太地區預計將成為組織工程3D生物列印市場成長最快的地區。這一成長主要得益於醫療保健和生物技術領域投資的增加、政府對再生醫學的扶持政策，以及中國、日本、韓國和印度等國研究活動的活性化。對先進組織工程解決方案、器官模型開發和個人化醫療日益成長的需求，正在加速大學、製藥公司和生物技術企業對生物列印技術的應用。日本和中國正在加強其在生物製造、生醫材料和再生醫學方面的能力，而醫療基礎設施的改善也為臨床應用拓展了機會。預計亞太地區在整個預測期內將保持最高的區域成長率。

主要趨勢和促進因素

患者特異性組織結構發育的擴展：

組織工程領域3D生物列印市場的關鍵趨勢是利用先進的生物列印技術開發患者特異性組織結構。研究人員和生物技術公司正在將3D生物列印機與生醫材料、生物墨水、幹細胞和數位成像技術結合，以創建具有可控形狀和生物學特性的組織結構。擠出、噴墨和雷射輔助生物列印技術的進步提高了細胞和生醫材料的空間沉積精度。這一趨勢正在推動人工皮膚、軟骨、骨骼、血管結構和其他組織的開發，同時也促進了人們對個人化再生醫學和能夠更真實地再現人體組織特徵的實驗模型的興趣。

對再生醫學和組織替代的需求日益成長：

組織工程領域3D生物列印市場的主要驅動力是人們對能夠修復或取代受損組織和器官的再生醫學解決方案日益成長的需求。傳統的組織和器官移植面臨許多挑戰，例如捐贈者短缺、組織相容性問題以及難以獲得合適的生醫材料。 3D生物列印提供了一種替代方案，它能夠利用活細胞和生醫材料來建構結構化的生物體。幹細胞技術、生醫材料、組織再生和器官製造等領域的研究進展正在推動對生物列印平台的投資。因此，為滿足組織修復方面尚未滿足的需求以及開發功能性生物替代品而不斷加大投入，正在支撐著市場成長。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 擠出型
    • 噴墨式
    • 雷射型
    • 微型閥類型
    • 其他
  • 市場規模及預測：依產品分類
    • 3D生物列印機
    • 生醫材料
    • 鷹架
    • 軟體
    • 其他
  • 市場規模及預測：依服務分類
    • 客製化原型開發
    • 諮詢
    • 維護
    • 訓練
    • 其他
  • 市場規模及預測：依技術分類
    • 磁浮
    • 立體光刻技術
    • 數位光處理
    • 融合積層製造
    • 其他
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
    • 生醫材料
    • 其他
  • 市場規模及預測：依應用領域分類
    • 組織工程
    • 藥物測試與開發
    • 再生醫學
    • 研究
    • 其他
  • 市場規模及預測：依材料類型分類
    • 水凝膠
    • 活細胞
    • 細胞外基質
    • 合成聚合物
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 研究機構
    • 生物製藥公司
    • 醫院
    • 學術機構
    • 其他
  • 市場規模及預測：依製程分類
    • 預處理
    • 加工
    • 後處理
    • 其他
  • 市場規模及預測：依功能分類
    • 細胞列印
    • 鷹架印刷
    • 器官印刷
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Organovo Holdings
  • CELLINK
  • Allevi
  • Aspect Biosystems
  • 3D Systems
  • RegenHU
  • EnvisionTEC
  • Cyfuse Biomedical
  • Poietis
  • Biogelx
  • Advanced Solutions Life Sciences
  • Pandorum Technologies
  • Prellis Biologics
  • Nano3D Biosciences
  • Rokit Healthcare
  • MatTek Corporation
  • TeVido BioDevices
  • CollPlant Biotechnologies
  • VIVAX BIO
  • Bioprinting Solutions

第9章 關於我們

簡介目錄
Product Code: GIS32810

The global 3D Bioprinting for Tissue Engineering Market is projected to grow from $1.4 billion in 2025 to $4.9 billion by 2035, at a compound annual growth rate (CAGR) of 13.3%. The 3D Bioprinting for Tissue Engineering Market is driven by growing demand for regenerative medicine, increasing research into engineered tissues, and advances in biomaterials and bioprinting technologies. According to the NIH, 3D bioprinting enables researchers to combine living cells with scaffolding materials to create complex three-dimensional tissue models. Advances in bioinks, stem cells, extrusion-based printing, laser-assisted techniques, and biomaterial engineering are enabling the development of customized tissue constructs for bone, cartilage, skin, and other applications. The FDA also identifies 3D-printed scaffolds with cells as an emerging regenerative medicine approach, supporting continued research and development.

The Type segment of the 3D Bioprinting for Tissue Engineering Market includes Extrusion-based, Inkjet-based, Laser-based, Microvalve-based, and Others. Extrusion-based bioprinting held the largest share in 2025, supported by its ability to print a wide range of biomaterials and cell-laden bioinks, scalability, and suitability for producing complex tissue scaffolds. Laser-based bioprinting is expected to be the fastest-growing segment, driven by its high printing precision, controlled cell placement, and increasing use in advanced tissue engineering and regenerative medicine. Inkjet-based and Microvalve-based technologies remain important for precise deposition of cells and biomaterials, while Others include emerging bioprinting approaches.

Market Segmentation
TypeExtrusion-based, Inkjet-based, Laser-based, Microvalve-based, Others
Product3D Bioprinters, Biomaterials, Scaffolds, Software, Others
ServicesCustom Prototype Development, Consulting, Maintenance, Training, Others
TechnologyMagnetic Levitation, Stereolithography, Digital Light Processing, Fused Deposition Modeling, Others
ComponentHardware, Software, Biomaterials, Others
ApplicationTissue Engineering, Drug Testing and Development, Regenerative Medicine, Research, Others
Material TypeHydrogels, Living Cells, Extracellular Matrices, Synthetic Polymers, Others
ProcessPre-processing, Processing, Post-processing, Others
End UserResearch Organizations, Biopharmaceutical Companies, Hospitals, Academic Institutes, Others
FunctionalityCell Printing, Scaffold Printing, Organ Printing, Others

The Application segment of the 3D Bioprinting for Tissue Engineering Market includes Tissue Engineering, Drug Testing and Development, Regenerative Medicine, Research, and Others. Tissue Engineering held the largest share in 2025, driven by increasing use of 3D bioprinting to develop biomimetic scaffolds, tissue constructs, and cell-based models for repairing or replacing damaged tissues. Regenerative Medicine is expected to be the fastest-growing segment, supported by advances in cell-based therapies, personalized medicine, organ and tissue fabrication, and bioprinted implant development. Drug Testing and Development is increasingly adopting bioprinted tissue models to improve drug screening, while Research applications continue to support technological development and validation.

Geographical Overview

North America held the largest share of the 3D Bioprinting for Tissue Engineering Market in 2025. The regions leadership is supported by advanced biotechnology and healthcare infrastructure, substantial research funding, and strong collaboration among universities, biotechnology companies, pharmaceutical firms, and medical institutions. The U.S. remains the primary contributor, with growing investments in regenerative medicine, tissue engineering, drug development, and bioprinted tissue research. Increasing clinical research into engineered tissues, alongside advances in bioinks, extrusion and light-based printing technologies, is strengthening commercial opportunities. Regulatory progress and rising investments in personalized and regenerative therapies are also supporting North America's dominant position.

Asia Pacific is expected to be the fastest-growing region in the 3D Bioprinting for Tissue Engineering Market during the forecast period. The region's expansion is supported by increasing healthcare and biotechnology investments, government initiatives for regenerative medicine, and growing research activity in China, Japan, South Korea, and India. Rising demand for advanced tissue-engineering solutions, organ-model development, and personalized medicine is encouraging universities, pharmaceutical companies, and biotechnology firms to adopt bioprinting technologies. Japan and China are strengthening capabilities in biofabrication, biomaterials, and regenerative medicine, while improving healthcare infrastructure is expanding opportunities for clinical applications. Asia Pacific is projected to register the highest regional growth rate through the forecast period.

Key Trends and Drivers

Increasing Development of Patient-Specific Tissue Constructs:

A key trend in the 3D bioprinting for tissue engineering market is the increasing development of patient-specific tissue constructs using advanced bioprinting technologies. Researchers and biotechnology companies are combining 3D bioprinters with biomaterials, bioinks, stem cells, and digital imaging to create tissue structures with controlled geometries and biological characteristics. Advances in extrusion, inkjet, and laser-assisted bioprinting are improving the ability to deposit cells and biomaterials with greater spatial precision. This trend is supporting the development of engineered skin, cartilage, bone, vascular structures, and other tissues while increasing interest in personalized regenerative medicine and laboratory models that better replicate human tissue characteristics.

Growing Demand for Regenerative Medicine and Tissue Replacement:

A key driver of the 3D bioprinting for tissue engineering market is the growing demand for regenerative medicine solutions capable of repairing or replacing damaged tissues and organs. Conventional tissue grafting and organ transplantation face challenges including donor shortages, tissue compatibility, and limited availability of suitable biological materials. 3D bioprinting offers an alternative approach by enabling the fabrication of structured biological constructs using living cells and biomaterials. Increasing research into stem-cell technologies, biomaterials, tissue regeneration, and organ fabrication is encouraging investment in bioprinting platforms. Growing efforts to address unmet needs in tissue repair and develop functional biological substitutes are therefore supporting market expansion.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Material Type
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Process
  • 2.10 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Extrusion-based
    • 4.1.2 Inkjet-based
    • 4.1.3 Laser-based
    • 4.1.4 Microvalve-based
    • 4.1.5 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 3D Bioprinters
    • 4.2.2 Biomaterials
    • 4.2.3 Scaffolds
    • 4.2.4 Software
    • 4.2.5 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Custom Prototype Development
    • 4.3.2 Consulting
    • 4.3.3 Maintenance
    • 4.3.4 Training
    • 4.3.5 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Magnetic Levitation
    • 4.4.2 Stereolithography
    • 4.4.3 Digital Light Processing
    • 4.4.4 Fused Deposition Modeling
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
    • 4.5.3 Biomaterials
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Tissue Engineering
    • 4.6.2 Drug Testing and Development
    • 4.6.3 Regenerative Medicine
    • 4.6.4 Research
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Material Type (2020-2035)
    • 4.7.1 Hydrogels
    • 4.7.2 Living Cells
    • 4.7.3 Extracellular Matrices
    • 4.7.4 Synthetic Polymers
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Research Organizations
    • 4.8.2 Biopharmaceutical Companies
    • 4.8.3 Hospitals
    • 4.8.4 Academic Institutes
    • 4.8.5 Others
  • 4.9 Market Size & Forecast by Process (2020-2035)
    • 4.9.1 Pre-processing
    • 4.9.2 Processing
    • 4.9.3 Post-processing
    • 4.9.4 Others
  • 4.10 Market Size & Forecast by Functionality (2020-2035)
    • 4.10.1 Cell Printing
    • 4.10.2 Scaffold Printing
    • 4.10.3 Organ Printing
    • 4.10.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Material Type
      • 5.2.1.8 End User
      • 5.2.1.9 Process
      • 5.2.1.10 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Material Type
      • 5.2.2.8 End User
      • 5.2.2.9 Process
      • 5.2.2.10 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Material Type
      • 5.2.3.8 End User
      • 5.2.3.9 Process
      • 5.2.3.10 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Material Type
      • 5.3.1.8 End User
      • 5.3.1.9 Process
      • 5.3.1.10 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Material Type
      • 5.3.2.8 End User
      • 5.3.2.9 Process
      • 5.3.2.10 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Material Type
      • 5.3.3.8 End User
      • 5.3.3.9 Process
      • 5.3.3.10 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Material Type
      • 5.4.1.8 End User
      • 5.4.1.9 Process
      • 5.4.1.10 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Material Type
      • 5.4.2.8 End User
      • 5.4.2.9 Process
      • 5.4.2.10 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Material Type
      • 5.4.3.8 End User
      • 5.4.3.9 Process
      • 5.4.3.10 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Material Type
      • 5.4.4.8 End User
      • 5.4.4.9 Process
      • 5.4.4.10 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Material Type
      • 5.4.5.8 End User
      • 5.4.5.9 Process
      • 5.4.5.10 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Material Type
      • 5.4.6.8 End User
      • 5.4.6.9 Process
      • 5.4.6.10 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Material Type
      • 5.4.7.8 End User
      • 5.4.7.9 Process
      • 5.4.7.10 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Material Type
      • 5.5.1.8 End User
      • 5.5.1.9 Process
      • 5.5.1.10 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Material Type
      • 5.5.2.8 End User
      • 5.5.2.9 Process
      • 5.5.2.10 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Material Type
      • 5.5.3.8 End User
      • 5.5.3.9 Process
      • 5.5.3.10 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Material Type
      • 5.5.4.8 End User
      • 5.5.4.9 Process
      • 5.5.4.10 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Material Type
      • 5.5.5.8 End User
      • 5.5.5.9 Process
      • 5.5.5.10 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Material Type
      • 5.5.6.8 End User
      • 5.5.6.9 Process
      • 5.5.6.10 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Material Type
      • 5.6.1.8 End User
      • 5.6.1.9 Process
      • 5.6.1.10 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Material Type
      • 5.6.2.8 End User
      • 5.6.2.9 Process
      • 5.6.2.10 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Material Type
      • 5.6.3.8 End User
      • 5.6.3.9 Process
      • 5.6.3.10 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Material Type
      • 5.6.4.8 End User
      • 5.6.4.9 Process
      • 5.6.4.10 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Material Type
      • 5.6.5.8 End User
      • 5.6.5.9 Process
      • 5.6.5.10 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Organovo Holdings
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 CELLINK
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Allevi
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Aspect Biosystems
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 3D Systems
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 RegenHU
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 EnvisionTEC
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Cyfuse Biomedical
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Poietis
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Biogelx
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Advanced Solutions Life Sciences
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Pandorum Technologies
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Prellis Biologics
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Nano3D Biosciences
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Rokit Healthcare
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 MatTek Corporation
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 TeVido BioDevices
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 CollPlant Biotechnologies
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 VIVAX BIO
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Bioprinting Solutions
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us